HOMEPRODUCTSSERVICESCOMPANYCONTACTFAQResearchDictionaryPharmaMobileSign Up FREE or Login

Plasma Cell Leukemia

A rare, aggressive variant of MULTIPLE MYELOMA characterized by the circulation of excessive PLASMA CELLS in the peripheral blood. It can be a primary manifestation of multiple myeloma or develop as a terminal complication during the disease.
Also Known As:
Leukemia, Plasma Cell; Leukemias, Plasma Cell; Leukemias, Plasmacytic; Plasma Cell Leukemias; Plasmacytic Leukemias; Leukemia, Plasmacytic; Plasmacytic Leukemia
Networked: 261 relevant articles (21 outcomes, 16 trials/studies)

Relationship Network

Disease Context: Research Results

Related Diseases

1. Multiple Myeloma
2. Residual Neoplasm
3. Plasmacytoma
4. Amyloidosis
5. Primary Myelofibrosis (Myelosclerosis)

Experts

1. Neri, Antonino: 4 articles (09/2015 - 02/2005)
2. Palumbo, Antonio: 3 articles (12/2015 - 06/2007)
3. Richardson, P: 3 articles (01/2014 - 07/2001)
4. Anderson, K C: 3 articles (01/2014 - 07/2001)
5. Musto, Pellegrino: 3 articles (06/2013 - 06/2007)
6. Fabris, Sonia: 3 articles (06/2013 - 02/2005)
7. Kruk, Barbara: 3 articles (02/2011 - 11/2004)
8. PogÅ‚ód, Ryszard: 3 articles (02/2011 - 11/2004)
9. Kraj, Maria: 3 articles (02/2011 - 11/2004)
10. Barlogie, Bart: 2 articles (12/2015 - 06/2014)

Drugs and Biologics

Drugs and Important Biological Agents (IBA) related to Plasma Cell Leukemia:
1. bortezomib (Velcade)FDA Link
2. Dexamethasone (Maxidex)FDA LinkGeneric
3. Melphalan (Alkeran)FDA LinkGeneric
4. Thalidomide (Thalomid)FDA Link
5. Immunoglobulin D (IgD)IBA
6. Cyclophosphamide (Cytoxan)FDA LinkGeneric
7. lenalidomide (CC 5013)FDA Link
8. Doxorubicin (Adriamycin)FDA LinkGeneric
9. Vincristine (Oncovin)FDA LinkGeneric
10. Prednisone (Sone)FDA LinkGeneric

Therapies and Procedures

1. Combination Drug Therapy (Combination Chemotherapy)
2. Drug Therapy (Chemotherapy)
3. Stem Cell Transplantation
4. Transplants (Transplant)
5. Peripheral Blood Stem Cell Transplantation (Peripheral Stem Cell Transplantation)